Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07065682

Effetivity of Dutasteride and Aloe Vera Extract Combination on Angiogenesis and Obstruction on Benign Prostatic Hyperplasia

Status
Recruiting
Phase
Phase 1
Study type
Interventional
Enrollment
84 (estimated)
Sponsor
Universitas Diponegoro · Academic / Other
Sex
Male
Age
50 Years
Healthy volunteers
Not accepted

Summary

This study is a double blinded RCT with pre-post test design on the effect of combination of dutasteride and aloe vera, compared to dutasteride only, on uroflowmetry results, prostate volume, and VEGF serum level among patients with benign prostate hyperplasia. The treatment was given for 12 weeks

Conditions

Interventions

TypeNameDescription
DRUGAloevera + dutasterideDutasteride 0,5 mg/day + Aloe Vera Extract 380 mg/day
DRUGDutasteride (0.5mg)Control

Timeline

Start date
2023-07-01
Primary completion
2024-12-01
Completion
2027-12-01
First posted
2025-07-15
Last updated
2025-07-15

Locations

1 site across 1 country: Indonesia

Source: ClinicalTrials.gov record NCT07065682. Inclusion in this directory is not an endorsement.

Effetivity of Dutasteride and Aloe Vera Extract Combination on Angiogenesis and Obstruction on Benign Prostatic Hyperpla (NCT07065682) · Clinical Trials Directory